My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1420

    1.

    TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.

    Howlin J, Rosenkvist J, Andersson T.

    Breast Cancer Res. 2008;10(2):R36. Epub 2008 Apr 24.PMID: 18435854 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.

    Hutcheson IR, Knowlden JM, Hiscox SE, Barrow D, Gee JM, Robertson JF, Ellis IO, Nicholson RI.

    Breast Cancer Res. 2007;9(4):R50.PMID: 17686159 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.

    Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE.

    Breast Cancer Res. 2007;9(5):R63.PMID: 17897439 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    [Inhibitory effects of siRNA targeting epidermal growth factor receptor on proliferation and invasion of human glioblastoma cells]

    Kang CS, Pu PY, Wang GX, Li YH, Dong L, Wang H.

    Zhonghua Yi Xue Za Zhi. 2004 Sep 17;84(18):1503-8. Chinese. PMID: 15500708 [PubMed - indexed for MEDLINE]Related articles

    6.

    Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.

    Dorssers LC, van Agthoven T, Brinkman A, Veldscholte J, Smid M, Dechering KJ.

    Breast Cancer Res. 2005;7(1):R82-92. Epub 2004 Nov 16.PMID: 15642172 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [Effects of RNA interference on epidermal growth factor receptor expression in breast cancer cells: a study in tumor-bearing nude mice]

    Wu WD, Fang CH, Yang ZX.

    Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jan;28(1):60-4. Chinese. PMID: 18227029 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation.

    Zheng X, Jiang F, Katakowski M, Zhang ZG, Lu QE, Chopp M.

    Cancer Biol Ther. 2009 Jun;8(11):1045-54. Epub 2009 Jun 25.PMID: 19395875 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion.

    Morishige M, Hashimoto S, Ogawa E, Toda Y, Kotani H, Hirose M, Wei S, Hashimoto A, Yamada A, Yano H, Mazaki Y, Kodama H, Nio Y, Manabe T, Wada H, Kobayashi H, Sabe H.

    Nat Cell Biol. 2008 Jan;10(1):85-92. Epub 2007 Dec 16.PMID: 18084281 [PubMed - indexed for MEDLINE]Related articles

    12.

    Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.

    Asanuma H, Torigoe T, Kamiguchi K, Hirohashi Y, Ohmura T, Hirata K, Sato M, Sato N.

    Cancer Res. 2005 Dec 1;65(23):11018-25.PMID: 16322251 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.

    Ibrahim YH, Byron SA, Cui X, Lee AV, Yee D.

    Mol Cancer Res. 2008 Sep;6(9):1491-8.PMID: 18819936 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

    Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.

    Breast Cancer Res. 2007;9(6):R76.PMID: 17980029 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.

    Shida D, Fang X, Kordula T, Takabe K, Lépine S, Alvarez SE, Milstien S, Spiegel S.

    Cancer Res. 2008 Aug 15;68(16):6569-77.PMID: 18701480 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.

    Oliveras-Ferraros C, Vazquez-Martin A, López-Bonet E, Martín-Castillo B, Del Barco S, Brunet J, Menendez JA.

    Int J Oncol. 2008 Dec;33(6):1165-76.PMID: 19020749 [PubMed - indexed for MEDLINE]Related articles

    18.

    An in vitro study on the suppressive effect of glioma cell growth induced by plasmid-based small interference RNA (siRNA) targeting human epidermal growth factor receptor.

    Kang CS, Pu PY, Li YH, Zhang ZY, Qiu MZ, Huang Q, Wang GX.

    J Neurooncol. 2005 Sep;74(3):267-73.PMID: 16132520 [PubMed - indexed for MEDLINE]Related articles

    19.

    Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor.

    Saxena NK, Taliaferro-Smith L, Knight BB, Merlin D, Anania FA, O'Regan RM, Sharma D.

    Cancer Res. 2008 Dec 1;68(23):9712-22.PMID: 19047149 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk